Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Feb 1.

Published in final edited form as: Ann Thorac Surg. 2013 Oct 17;97(2):506–512. doi: 10.1016/j.athoracsur.2013.08.048

Table 5.

Post-transplant Outcomes Before and After Propensity Matching

	Unadjusted		Propensity Matching
	HR^* (95% CI)	p-value	HR^* (95% CI)	p-value
Patient Survival	1.100 (0.681, 1.778)	0.697	0.833 (0.417, 1.664)	0.598
Rejection	0.745 (0.275, 2.022)	0.564	0.821 (0.220, 3.064)	0.726
CAV	1.512 (0.792, 2.886)	0.210	1.557 (0.580, 4.176)	0.344
	*OR^ (95% CI)**	p-value	*OR^ (95% CI)**	p-value
Post-transplant dialysis	1.291 (0.759, 2.194)	0.345	0.920 (0.460, 1.842)	0.815
Pacemaker implantation	1.205 (0.545, 2.666)	0.645	2.437 (0.599, 9.907)	0.716
Post-transplant stroke	1.648 (0.692, 3.920)	0.254	2.052 (0.580, 7.254)	0.265
30-day mortality	0.456 (0.142, 1.460)	0.280	0.274 (0.055, 1.374)	0.116
	*Beta^ (95% CI)**	p-value	*Beta^ (95% CI)**	p-value
Length of stay (days)	0.684 (−2.406, 3.774)	0.663	−2.366 (−8.719, 3.987)	0.465

^*

For Heartware (Heartmate II is referral group)